Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology
Loanna Mela, Assistant Professor at University of Cambridge, shared a post on LinkedIn:
“We are very excited to be recruiting a Research Associate on DNA nanotechnology approaches for the targeting of activated platelets!
Do get in touch if you are interested!”
Department of Pharmacology, University of Cambridge shared a post on LinkedIn:
“Recruiting: Research Assistant/Associate, closes 4th October
Applications are invited for a Postdoctoral Research Associate position in DNA nanotechnology for the targeted delivery of fibrinolytics to activated platelets, in the groups of Dr Ioanna Mela and Prof. Matthew Harper.
The successful candidate will conduct research on the design, synthesis and functionalisation of DNA nanostructures, to carry both targeting molecules and active payloads to activated platelets.
The aim of the project is to i) develop new DNA nanostructures for optimal interaction with activated platelets ii) characterise and quantify the effects of targeted fibrinolytic delivery to thrombi through a variety of biophysical methods.
The applicant should have (or be about to obtain) a PhD in a relevant specialist subject and a background in DNA nanotechnology, microscopy or related disciplines.
All candidates should have a keen interest in applying biophysical methods to complex biological systems and enjoy working in a highly multidisciplinary, dynamic and collaborative environment.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:04Ben Samelson-Jones: Do Gene Variants Drive PK Differences in FIX-Fusion and N9-GP Therapies?
-
Sep 23, 2026, 12:57Shelly Reed: Advocating for HTCs and CDC Funding with the Hemophilia Federation of America
-
Sep 23, 2026, 12:51Domenico Girelli: How Verona Hospital Transformed ED Anemia Care with Patient Blood Management
-
Sep 23, 2026, 12:45Lina Camacho-Arteaga: ENTIS Study Uncovers Safety Data on Early Pregnancy Exposure to Direct Oral Anticoagulants